City of Hope Cancer Center — Duarte, California

Public research footprint of City of Hope Cancer Center, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non Small Cell Lung Cancer · Primary Cutaneous CD8-Positive Aggressive Epidermotropic T-Cell… · Breast Cancer · Relapsed Diffuse Large B-Cell Lymphoma

Recently updated registry entries

NCT07573215 — Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic… (Available)
NCT01804686 — A Long-term Extension Study of PCI-32765 (Ibrutinib) (Recruiting)
NCT06667076 — A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at City of Hope Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.